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Summary. Human growth hormone (GH) has recently 
been found to stimulate osteoclastic resorption, cysteine- 
proteinase and metalloproteinase activities (MMP-2 and 
MMP-9) in vitro via insulin-like growth factor-1 (IGF-1) 
produced by stromal cells.  The  present study 
investigated the effects of two extracellular matrix 
components (vitronectin and type-1 collagen) on hGH- 
and hIGF-1-stimulated osteoclastic resorption and 
proteinase activities in a rabbit bone cell model. After 4 
days of rabbit bone cell culture on dentin slices with 
vitronectin coating, hGH and hIGF-1 stimulated bone 
resorption and hIGF-1 upmodulated cysteine-proteinase 
activities. MMP-2 expression (but not resorption, 
cathepsin or MMP-9 activities) was upmodulated by 
hGH and hIGF-1 on dentin slices coated with type 1 
collagen as compared to those without coating. Then, 
vitronectin was synergistic with hIGF-1 in the regulation 
of cysteine-proteinase production whereas collagen 
showed synergy with hGH and hIGF-1 in the regulation 
of MMP-2 production. Anti-avB3 totally abolished the 
effects of hGH and hIGF-1 on metalloproteinase release, 
but had no influence on cathepsin release. The results 
suggest that cysteine-proteinase modulation is not 
mediated by avB3 integrin (strongly expressed on 
osteoclastic surface) whereas the resorption process and 
metalloproteinase modulation are clearly'mediated by 
this integrin. Our finding about the collagen coating also 
suggests that hGH- and hIGF-1-stimulated MMP-2 
activity are mediated, along with avB3 integrin, by 
another adhesion molecule. 
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lntroduction 
Regulation of the longitudinal growth of long bones 
is influenced by cytokines and growth hormones. Human 
growth hormone (hGH) acts directly on osteoblasts and 
exerts anabolic effects on bone formation. Although 
some studies have indicated that hGH plays an essential 
role in the maintenance of bone mass in adulthood and 
contributes to the bone remodeling process, its effects on 
osteoclasts are not well-documented (Isaksson et al., 
1987). hIGF-1, a mediator of hGH action on osteoblastic 
cells, has been shown to stimulate osteoclastic resorption 
by means of osteoblastic cells (Hill et al., 1995).The 
stromal cell-mediated action of hGH on bone resorption 
may be due to an increase in hIGF-1 production 
(Guicheux et al., 1998) 
Osteoclast adhesion to the bone matrix is necessary 
for bone resorption. This process involves not only 
growth factors, cytokines and chemoattractants but also 
a series of cell-matrix and cell-cell interactions leading 
to invasion, migration and anchorage of osteoclasts to 
the bone surface. Osteoclasts interact with the organic 
matrix on bone surface prior to the creation of the bone 
resorption compartment. Adhesive interactions of 
osteoclasts with the organic matrix (mediated by the 
integrin group of adhesion molecules) occur 
preferentially on type 1 collagen, the major protein of the 
bone matrix, and on RGD (Arg-Gly-Asp) peptide- 
containing proteins such as vitronectin and osteopontin. 
Specific receptors on osteoclast plasma membrane, such 
as avB3 integrin (VNR), interact with RGD-containing 
proteins including vitronectin (Helfrich et a1.,1992, 
1996; Shankar et al., 1995). Severa1 groups have shown 
that the vitronectin receptor is essential in the attachment 
of osteoclasts to bone surface and that the suppression of 
VNR interaction with its natural ligand in the bone 
matrix induces osteoclast detachment and inhibits bone 
resorption (Fishert et al., 1993). Although adhesion 
molecules are likely to be present in the sealing zone, the 
localization of VNR remains controversial. VNR have 
been reported within the sealing zone by certain authors 
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(Vaananen and Horton, 1995) and not observed by 
others (iakkakorpi et al., 1991). Lakkakorpi et al. (1991) 
have demonstrated by immunofluorescence, 
immunoperoxidase staining and immunoelectron 
microscopy that VNR is localized only at the ruffled 
borders and basolateral membranes (expect in the 
sealing zone areas) in rat and chicken osteoclasts. In 
addition to VNR, two other integrins, a2B1 and a v p l ,  
have been identified on osteoclasts (Nesbitt et al., 1993). 
Helfrich et al. (1996) have shown that a281 acts as a 
receptor for native type 1 collagen on osteoclasts, 
whereas osteoclast adhesion to denatured collagen 
involves avB3 suggesting different levels of control via 
adhesion mechanisms during the resorption process. 
Thus, initial recognition of native collagen utilizes a2B1 
integrin. Later, during the resorption phase of osteoclast 
activity when collagen is digested through a low pH in 
the subosteoclastic compartment, osteoclast adhesion to 
digested collagen, and spreading on this substrat, may 
involved the shift in the protein-receptor interactions and 
the participation of avB3. Subsequent to these cell 
matrix interactions, proteases may be involved in the 
access of osteoclasts to their future resorption sites and 
in degradation of the extracellular matrix (Sato et al., 
1998). 
The degradation of bone proteins is largely caused 
by cysteine-proteinases, which are optimally active at 
the low pH occurring beneath osteoclasts. Cathepsin B 
and L have been identified in osteoclasts and shown to 
be capable of depolymerizing and solubilizing collagen 
under the conditions likely to occur  beneath the 
osteoclast in the subosteoclastic compartment during 
resorption (Delaisse et al., 1984). Cathepsin K is 
abundant and selectively expressed in osteoclasts and 
seems to play a specialized role in bone resorption 
(Drake et al., 1996). Matrix metalloproteases (MMPs) 
are zinc-dependent endopeptidases which catalyse the 
degradation of the extracellular matrix. These enzymes 
secreted in latent form are blocked by specific tissue 
inhibitors (TIMPs). The prevention of bone resorption 
by MMP inhibitors has provided direct evidence for the 
participation of MMPs in bone resorption (Hill et al., 
1994). The gelatinases, a subgroup of MMPs (also 
known as type IV collagenases), degrade gelatin 
(denatured collagen) and type IV, V, VII, IX and X 
collagens. Some investigations have found that cysteine- 
proteinases are required for degradation of matrix 
proteins in resorption lacunae, but not for osteoclast 
activation. Conversely, collagenases, produced by the 
osteoblastic lineage, seem essential for the initiation of 
bone resorption by generating collagen fragments that 
activate osteoclasts to resorb bone (Holliday et al., 
1997). Chambers et al. (1985) found that collagenase can 
predispose bone surfaces to resorption, and Lorenzo et 
al. (1992) showed that isolated rabbit osteoclasts express 
MMP-2 (known also as 72-kDa gelatinaseltype IV 
collagenase transcripts/gelatinase A) and MMP-9 
(known also as 92-kDa gelatinaseltype IV collagenase 
transcriptslgelatinase B). Okada et al. (1995) suggested 
that MMP-9 degrades bone collagens in the 
subosteoclastic microenvironment, in conjunction with 
other proteinases such as  MMP-1 and cysteine- 
proteinases. Cysteine-proteinases and MMPs can be 
modulated by hormones and cytokines. However, the 
effects of these cytokines on protease production by 
osteoclasts is not clearly understood. 
In this context, a total rabbit bone cell model was 
used to analyze the effects of organic matrix proteins 
(type 1 collagen and vitronectin) on hGH and hIGF-1- 
stimulated osteoclastic resorption and to study proteinase 
activities. 
Materials and methods 
Reagents 
Recombinant human GH (hGH, Umatrope, 16 IU) 
was a generous gift from the Lilly Company (Saint 
Cloud, France), and 1-a,25-dihydroxyvitamin D3 (VD3) 
was kindly provided by Drs. E.M. Gutknecht and P. 
Weber (Hoffmann-La Roche, Basel, Switzerland). 
Recombinant human IGF-1 (hIGF-1) was supplied by 
R&D Systems (Abington, UK). Mouse monoclonal 
antibodies against avB3 [(clone 23C6) immunogen used 
: osteoclasts from osteoclastomas] were obtained from 
Chemicon International, Inc. (Temecula, CA). Type 1 
collagen (extracted in acid from porcine tendons) and 
human vitronectin were purchased respectively from 
Nitta Gelatin Co. (Osaka, Japan) and Becton Dickinson 
(Le Pont-de-Claix, France). a-Minimal  essential 
medium (a-MEM) and fetal bovine serum (FBS) were 
supplied by Gibco (Eragny, France). Human parathyroid 
hormone (hPTH), Z-Phe-Arg-AMC substrate (7-N- 
benzyloxycarbonyl-Lphenylalanyl-Larginylamide-4- 
methylcoumarine), E64 (specific inhibitor of cysteine 
proteinases [L-trans-epoxysuccinyl-leucylamido (4- 
guanidino) butane] were obtained from Sigma. 
Recombinant MMP-9 and MMP-2 were purchased from 
R&D System. 
Cell culture 
Neonatal rabbit bone cells were isolated using a 
previously reported method (Yamada et al., 1997). 
Briefly, 13-day-old rabbits were killed by cervical 
dislocation, and their long bones isolated and freed from 
soft tissue, minced with scissors and placed in vortex in 
a-MEM medium. After sedimentation for 2 min, the cell 
suspension was harvested (repeated twice) and were 
washed in a-MEM. The cells were then seeded in a- 
MEM supplemented with 10% fetal bovine serum into 
24-well plates at a density of lo7 cells/well. The cultures 
were maintained in a humidified 95% air, 5% C 0 2  
atmosphere at 37°C for 4 days. Cells were incubated for 
the last 24 h of culture in serum-free a-MEM with or 
without hGH (1, 10, 50 ng/ml), hIGF-1 (1, 10, 50 ng/ml) 
or hPTH (50 ng/ml), VD3 (10-8 M), an association of 
anti-avB3 (10 pglml) with hIGF-1 (50 nglml), or an 
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association of anti-avB3 (10 mglml) with hGH (50 
ngíml). 
Pit resorption assay 
The resorption activity of osteoclasts from the total 
rabbit bone cell preparation was estimated by pit 
formation on sperm whale dentin slices coated or not 
with vitronectin or type 1 collagen, washed three times 
with phosphate-buffered saline solution (PBS), and 
placed in 24-well plates. Cells were then plated for the 
last 24 h of culture in serum-free a-MEM with or 
.f without the different factors, at a density of 10 cells per 
well containing dentin slices. Dentin slices were 
sonicated for 2 min in distilled water and gold 
palladium-coated for scanning electron microscopic 
studies (SEM) on a semiautomatic image analyzer 
(Q500 Quantimeter, Leica, Cambridge, UK). The 
resorption activity of cells was analyzed in terms of the 
percentage of dentin surface area resorbed. 
Collagen and vitronectin coating 
Al1 experiments were performed on dentin slices 
with or without a coating of human vitronectin and type 
1 collagen extracted in acid from porcine tendons. The 
collagen solution (0.3 % Cellmatrix 1-A) was mixed ice- 
cold with x 10 concentrated a-MEM and 0.2M 
HEPESINaOH (pH 7.4) containing 2.2% Naco3 at a 
ratio of 8:l:l. One milliliter of this mixture was poured 
into each well and incubated at 37 "C for 10 min 
according to the manufacturer. The vitronectin solution 
was prepared in PBS at 10 mg/ml, and 100 m1 were 
incubated on a dentin slice for 1 h at 37 "C according to 
the manufacturer. 
Cathepsin activity measurements and determination of 
total protein concentrations 
Cathepsin K, B and L activities were determined by 
the action of a non-specific fluorogenic substrate, Z-Phe- 
Arg-AMC, as previously reported (Rousselle et al., 
2000). Cathepsin activities were determined in 
supernatants. Briefly, 50 ,u1 of cell culture supernatants 
was incubated in 140 ,u1 of lOOmM sodium acetate 
buffer, pH 5.5 containing 1 mM EDTA and 0.1 mM 
freshly prepared DTI' at 37 "C. The reaction was started 
by addition of 100 m1 substrate (5  mM assay 
concentration) and stopped by addition of 100 m1 of 100 
mM sodium iodoacetate in 50 mM TriskiCl buffer, pH 
8.0. For fluorescence, the excitation and emission 
wavelengths were respectively 365 and 465 nm. Specific 
cathepsin activities were expressed as nmol of 
hydrolyzed substrate.h-l.mg proteirl. 
Measurement of matrix metalloproteinase activity 
Matrix metalloproteinase activity was determined by 
zymography as previously described (Rousselle et al., 
2000). MMP activities were detected in cell culture 
supernatants. Electrophoresis gel was composed of 10% 
polyacrylamide gel containing 0.1% gelatin. A standard 
enzyme preparation containing both active MMP-2 and 
MMP-9 was used as reference of molecular weights. 
Proteinase activity was apparent as clear (unstained) 
regions. Stained polyacrylamide gels were observed with 
a video camera, allowing transfer to software for image 
processing (Q500 Quantimeter) and isolation of 
migration bands. Gelatinase activity was expressed as a 
percentage (shades of grey compared to the control). 
Statistical analysis 
Al1 experiments were done three times in triplicate. 
The mean ? SD was calculated for al1 conditions and 
compared by ANOVA. Differences relative to a 
probability of two-tailed p<0.05 were considered 
significant. 
Results 
Vitronectin but not collagen enhances the resorption 
capability of rabbit bone celis 
As revealed by cytological analysis, osteoclasts, with 
resorption capability, were differentiated from total 
rabbit bone cells (Rousselle et al., 2000; data not 
shown). VD3, hPTH, hGH and hIGF-1 enhanced 
significantly the area resorbed compared to the control 
without soluble factor (Fig. 1) (Guicheux et al., 1998). 
No modulation was observed in presence of type 1 
collagen coating and VD3, hPTH, hGH and hIGF-1 had 
the same stimulator effect on area resorbed. 
Vitronectin coating of dentin slices upmodulated the 
resorption capability of rabbit bone cells. The total area 
resorbed was markedly increased (6-fold) in the 
presence of vitronectin. To determine the potential 
synergy between vitronectin and the soluble factors 
studied (VD3, hPTH, hGH or hIGF-1), similar 
experiments were conducted using al1 possible 
combinations. Figure 1 shows that vitronectin, but not 
collagen, was synergistic with these four factors. Thus, 
the effects of ~ O - ~ M  VD3, 50 ng/ml hPTH, 50 ng/ml 
hGH and 50 ng/ml hIGF-1 were increased respectively 
about 3.8-, 2.6-, 4- and 4.6-fold more in the presence of 
vitronectin than without matrix protein. Moreover, 
antibodies against avB3 integrin reduced the basal 
resorption activity of total rabbit bone cells significantly 
(about 53%). These antibodies significantly inhibited the 
resorption activity induced by 50 ng/ml hPTH, 50 ng/ml 
hGH and 50 ngíml hIGF-1 (about 86%, 52% and 85% 
respectively), as compared to basal activity. This 
inhibition was specific since a mouse isotype antibody 
(IgG) did not induce the same effect (data not shown). 
Vitronectin was synergistic with hlGF- 1 in regulating 
cathepsin production by total rabbit bone cells 
VD3 M) (data not shown), hGH and hIGF-1 
(50 nglml) increased the production of cathepsin 
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(inhibition by E64) by total rabbit bone cells whereas 
hPTH (50 ngíml) had no effect (Fig. 2) (Rousselle et al., 
2000). No modulation of cathepsin activities was 
observed with type 1 collagen coating of dentin slices 
and the different factors had the same effect on the 
production of cathepsins as without matrix protein. 
Thus, 50 ngíml hGH and 50 ngíml hIGF-1 upmodulated 
the cathepsin activity of rabbit bone cells about 1.8-fold 
as compared to the control without soluble factor (Fig. 
o\ 
LI. 
Vitronectin coating of dentin slices did not modify 
the basa1 production of cathepsins by rabbit bone cells. 
The effect of hGH on cathepsin activity was not 
influenced by vitronectin coating, whereas the 
production of cathepsins induced by 50 ng/ml hPTH and 
50 nglml hIGF-1 was respectively 5- and 2-fold higher in 
the presence of vitronectin than without matrix protein 
(Fig. 2). These results indicate that hIGF-1 and hPTH 
were synergistic with vitronectin in regulating cysteine- 
proteinase production. Moreover, no inhibition of 
cysteine-proteinase activity was detected in the presence 
of anti-avB3 antibodies in any of the conditions tested 
(data not shown). n control  VD^ 
Collagen was synergistic with hGH and hlGF-1 only in 
regulating MMP-2 production by total rabbit bone cells 
Two bands, inhibited by EDTA, of about 92 
control , 1 10 50 I I I 
hGH (50 nglml) control hPTH hGH hIGF- 1 
Fig. 2. Effects of bone matrix proteins on cysteine-proteinase activities 
released by unfractionated rabbit bone cell culture. Total rabbit bone 
cells were cultured for 4 days on dentin slices without (hatched 
histograrns) or with type I collagen (grey histograms) or vitronectin 
coating (dark histograrns) in the absence or presence for the last 24 h of 
culture of hPTH (50 ng/ml), hGH (50 ng/ml), hlGF-I (50 ng/ml) or vehicle 
(control). Results are the rnean I SD of three separate experiments 
periormed in quintuplicate. *:p<0.05; *:p<O.Ol; -:p<0.001 compared to 
the control. 
Fig. 1. Effects of bone matrix proteins on the resorption activity of 
osteoclasts frorn unfractionated rabbit bone cell culture. Total rabbit bone 1 cells were cultured for 4 days on dentin slices without (hatched histograms) or with type I collagen (grey histograms) or vitronectin coating (dark histograms) in the absence or presence for the last 24 h of culture of hPTH 
o (50 ng/rnl) (a), VD3 (10-*M) (a), hGH (1, 10, 50 ng/ml) (b), hlGF-I (1, 10. 50 
N control , 1 10 50 ng/rnl) (c) or vehicle (control). Results are the mean I SD of three separate 1 experiments performed in triplicate. *:p<0.05; **:p<0.01; ***:p<0.001 
hIGF-l(50 nglml) cornpared to the control. 
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(corresponding to gelatinase B, MMP-9 or type IV 
collagenase in its latent form) and 62 kDa (known as 
gelatinase A or MMP-2 in its active form) were 
observed as previously described with this rabbit bone 
cell model (Fig. 3) (Rousselle et al., 2000). The accurate 
molecular weights were determined using molecular 
weight markers and recombinant MMP-2 and MMP-9. 
An additional band at 184 kDa was observed in al1 
culture conditions used. The intensity of the last band, 
was not modulated by addition of hPTH, hGH and hIGF- 
1 in the culture medium. hPTH, hGH and hIGF-1 (50 
ng/ml) upmodulated MMP-2 and MMP-9 activities of 
rabbit bone cel ls  (Fig. 4). No modulation of 
metalloproteinase activity was observed in the presence 
of type 1 collagen coating as compared to dentin slices 
without coating. Type 1 collagen coating did not 
influence the effect of hGH and hIGF-1 on MMP-9 
activity (Fig. 4a), whereas in the presence of collagen, 
hGH and hIGF-1 increased MMP-2 activity respectively 
about 3.1-fold and 3.6-fold as compared to the control 
without collagen (Fig. 4b). These results indicate that 
hGH and hIGF-1 were synergistic with type 1 collagen in 
regulating MMP-2 production. 
No modulation of metalloproteinase activities was 
observed in the presence of vitronectin coating (Fig. 3) 
compared to the control without coating (Fig. 4, 
Rousselle et al., 2000) and no synergy occurred between 
vitronectin and hPTH, hGH or hIGF-1 compared to each 
condition alone. Anti-avB3 integrin antibodies 
significantly strongly inhibited the effects of 50 ng/ml 
hPTH (data not shown), 50 nglml hGH and 50  ng/ml 
hIGF-1 on MMP-2 and MMP-9 production (Fig. 3). This 
inhibition was specific since a mouse isotype antibody 
(IgG) did not induce the same effect (data not shown). 
Discussion 
This study used a total bone cell model to analyze 
the effects of organic matrix proteins (type 1 collagen 
and vitronectin) on hGH and hIGF-1-stimulated 
resorption and to investigate proteinase activities. This 
work showed that vitronectin was synergistic with hGH 
and hIGF-1 in the regulation of bone resorption and with 
hIGF-1 in the regulation of cysteine-proteinase 
production. Moreover, collagen only modulated MMP-2 
production. The  effects of hGH and hIGF-1 on 
metalloproteinase release were totally abolished when 
anti-avB3 was added to the culture medium, but these 
antibodies had no influence on cathepsin release. This 
study confirms our recent report that hGH and hIGF-1 
stimulates osteoclastic bone resorption in vitro 
(Guicheux et al. ,  1998) and shows that cysteine- 
proteinases, MMP-9 (latent form) and MMP-2 (active 
form) were markedly induced by hIGF-1 and hGH 
(Rousselle et al., 2000). Indeed, in our previous report, 
we demonstrated that hGH stimulates osteoclastic 
resorption and proteinase activities via hIGF-1 produced 
by stromal cells. Our present study was extended to 
include the role of bone matrix proteins on these 
mechanisms and demonstrated a mediation, along with 
hIGF-1, of bone resorption and proteinase activities by 
adhesion molecules. 
Many cell types [mainly osteoblastic cells (stromal 
cells)] but also cytokines, growth factors and other 
molecules are highly involved in the control of these 
mechanisms (Heymann et al., 1998). Adhesion 
control hGH (50 nglml) hlGF-1 (50 ng/ml) 
- anti-avp3 I I - anti-avpó'  
Flg. 3. 
Metalloproteinase 
activiies released by 
unfractionated rabbi 
bone cells. Total 
rabbit bone cells 
were cultured on 
dentin slices coated 
with vitronectin for 
the last 24 h with or 
without hGH (50 
ng/ml) or hlGF-I (50 
ng/ml) in the absence 
or presence for the 
last 24 h of culture of 
anti-avB3 integrin (1 0 
~g/ml). 
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molecules (mainly integrins) are also implicated in 
processes of osteoclast attachment to organic substrates 
(Suda et al., 1995). Osteoclasts express an avB3 integrin 
receptor, which recognizes an RGD (arg-gly-asp) 
sequence contained in vitronectin, fibronectin and 
osteopontin, and an a2B1 integrin receptor which 
recognizes type 1 collagen (Nesbitt et al., 1993; Helfrich 
et al., 1996). Thus, osteoclast adhesion to the bone 
surface plays a key role during bone resorption. 
Vaananen and Horton (1995) found specific interactions 
(cell-extracellular matrix) in the clear zone of osteoclasts 
which could induce the activation of these cells. 
Although the cellular mechanisms involved in the 
formation of the clear zone are poorly understood, this 
step is essential in the process of bone resorption since 
the clear zone confines acidic solubilization of bone 
mineral to the area directly beneath the ruffled border. In 
the present work, osteoclastic resorption was not 
modulated by bone cell interactions with type 1 collagen, 
but was upmodulated by vitronectin coating on dentin 
slices. Bone cell interactions with vitronectin influenced 
the resorption capability of rabbit bone cells and were 
synergistic with hGH and hIGF-1. These results suggest 
that binding to vitronectin was more efficient than to 
type 1 collagen for the resorption capability of rabbit 
bone cells. The modulation of integrin expression in the 
presence of various growth factors could account for 
these events (Ruoslahti et al., 1994). These data are 
consistent with those of Horton et al. (1985), who 
showed that antibodies against vitronectin receptor 
inhibited osteoclastic resorption by rat osteoclasts and 
our present study confirms that the addition of anti-avB3 
to the culture medium totally inhibited the resorption 
activity induced or not by hGH and hIGF-1. It has been 
reported that echistatin, a naturally-occurring protein 
containing RGD-sequences, blocks osteoclast 
attachment to bone and inhibits bone resorption in vitro 
(Fisher et al., 1993). Recently, Villanova et al. (1999) 
have also shown that a v  antisense oligodeoxynucleotide 
(ODN) caused a dose-dependent, substrate-specific 
reduction of osteoclast adhesion. ODN also induced 
osteoclast retraction, apoptosis and inhibited bone 
resorption. These results strengthen the fact that avB3 
integrin-induced adhesion of osteoclasts to bone surface 
plays an important role in the osteoclast resorption 
function. 
Although extracellular matrix components markedly 
b influenced proteinase activities, they seemed to act 
..S 
differently with cysteine-proteinase and metallo- 
400 proteinase. Vitronectin showed no synergy with hGH 
and hIGF-1 in the regulation of MMP production. Only 
h 
m hIGF-1 was synergistic with vitronectin in the regulation 
" a00 of cysteine-proteinase production and vitronectin 
b8 prevented the hGH effect which in turn could stimulate 
'= 3 proteinase activities via IGF-1 production (Rousselle et 1s 200 al., 2000). The effects of hGH and hIGF-1 on vitronectin-coated dentin slices differed from those on 
dentin slices coated with type-1 collagen. In the latter ii 100 case, hGH and hIGF-1 did not influence the cysteine- -- proteinases released by total rabbit bone cells and only 
U showed synergy with collagen in the regulation of 
MMP-2 production. These results are in agreement with 
o those recently reported by Sato et al. (1998), who found 
hFTH hGH hIGF- 1 that cysteine-proteinases, as compared to MMPs, played 
Fig. 4. Effect of type I collagen on metalloproteinase activities released 0nly a minor role during osteoclast invasion by type-1 
by unfractionated rabbit bone cells. Total rabbit bone cells were cultured collagen- In their m0de17 MMP-2 activit~ t0 play 
for 4 days on dentin slices without (hatched histograms) or with type 1 a key r0le in the migration of 0Ste0~laStS and in access to 
collagen (grey histograms) coating in the absence or presence for the their future resorption. As cysteine-proteinase activities 
last 24 h of cu~ture of hPTH (50 ndml), hGH (50 ndml) or hlGF-1 (50 may be necessary for collagenolytic activity near the MMP-9 (a) and MMP-2 (b) activities are expressed as osteoclast resorption zone (Foged et al., 1996), rnigration percentages (shades of grey compared to the control). Results are the 
mean + SD of three separate cultures tested. *L: p<0.01, m: p<0.001 resOr~tiOn functiOns cOuld be mediated variOus 
compared to the control. proteolytic activities. 
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Addition of anti-avB3 to the culture medium totally 
abolished GH- and IGF-1-stimulated bone resorption and 
their effects on matrix metalloproteinase release, but had 
no influence on cathepsin release. The avB3 antibody 
used (clone 23C6) was prepared from osteoclasts of 
giant cell tumors. Immunocytochemical studies have 
shown that this antibody preferentially binds osteoclasts 
strongly expressing these antigens (Horton et al., 1985). 
This suggests that cysteine-proteinase modulation was 
not mediated by avB3 integrin whereas the resorption 
process and the metalloproteinase modulation were 
clearly mediated by avB3. Osteoclast adhesion to the 
extracellular matrix by avB3 integrin seems to be 
essential for the hGH- and hIGF-1-stimulated resorption 
and metalloproteinase activity but not for the cysteine- 
proteinase activity. These data are consistent with those 
of Brooks et al. (1996) who found that avB3 integrin on 
the surface of tumor cells binds to MMP-2. Moreover, 
the deletion of a v  integrin led to a decreased ability to 
spread on vitronectin and suppressed MMP-2 expression 
(Koistinen et al., 1999). However, in presence of 
collagen, hGH and hIGF-1 only stimulated MMP-2 
expression. These findings also suggest that hGH- and 
hIGF-1-stimulated MMP-2 activity were mediated, 
along with avB3, by another adhesion molecule. 
In a recent study, experiments realized on purified 
rabbit osteoclasts have revealed that MMP expression by 
osteoclasts was directly regulated by hIGF-1 while 
hIGF-1 had no effect on cysteine-proteinase activities 
released by osteoclasts (Rousselle et al., 2000). The 
present paper found that avB3 abolished hGH- and 
hIGF-1-stimulated bone resorption and their effect on 
MMP release but had no influence on cathepsin release. 
Moreover, avB3 integrin is strongly expressed on 
osteoclastic surface.  These support the previous 
hypothesis indicating that non-osteoclastic bone cells 
may have been the source of cathepsin production in our 
culture model while MMPs were mainly expressed by 
osteoclastic cells (MMP-2 and MMP-9 basa1 production 
involving non-osteoclastic bone cells). 
In summury, the synergy of vitronectin, hGH and 
hIGF-1 increased the resorption activity of total rabbit 
bone cells. This work showed that vitronectin was also 
synergistic with hIGF-1 in the regulation of cysteine- 
proteinase production and type 1 collagen showed only 
synergy with hGH and hIGF-1 in the regulation of 
MMP-2 expression. This  study suggests  that the 
resorption process and the metalloproteinase modulation 
are mediated by avB3 whereas cysteine-proteinases 
seem to have another regulation pathway. In presence of 
collagen, hGH- and hIGF-1-stimulated MMP-2 activity 
is also mediated by another adhesion molecule. 
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